The Irving Institute for Clinical and Translational Research has been awarded a seven-year, $75 million Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH).
As a cornerstone of clinical and translational research across Columbia University Irving Medical Center (CUIMC), the Irving Institute drives translational science by supporting and advancing the full biomedical research enterprise of the University. The Irving Institute’s infrastructure, education, services, and strategic support enable CUIMC investigators to move discoveries from bench to bedside more efficiently and with greater impact.
The grant will advance clinical and translational research by:
- Providing critical seed funding to expand novel approaches to clinical and translational science. Launching a first-of-its-kind pilot program to return individual research results to study participants using AI-assisted tools and community health worker support.
- Enhancing collaboration with local communities through the Stakeholders in Translational Research (STAR) Ambassadors and Community Health Workers programs, ensuring bi-directional learning and decision-making.
- Advancing CUIMC’s AI and data science capabilities for research, including tri-institutional Data Lake House, federated learning infrastructure, clinical data phenotyping tools, and embedded clinical trial systems.
- Investing in training and professional development for investigators, from PhD trainees to senior faculty, and allied research personnel—with new programming in AI for research, team science, grant development, mentorship, and research leadership.
- Expanding Columbia’s reach through the national CTSA network(link is external and opens in a new window) ensuring innovations are adopted, sustained, and scaled beyond our institution.
